SearchDictionaryMobileLogin

Prolonged low doses of oral etoposide may be effective in individual patients with advanced lymphoproliferative disorders refractory to aggressive chemotherapy.

AuthorsR Caruso, F Alesiani, R Latagliata
JournalHaematologica (Haematologica) 1997 Jan-Feb Vol. 82 Issue 1 Pg. 126-7 ISSN: 0390-6078 ITALY
PMID9107103 (Publication Type: Letter)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Etoposide
Topics
  • Administration, Oral
  • Adult
  • Aged
  • Antineoplastic Agents, Phytogenic (administration & dosage, adverse effects, therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Drug Evaluation
  • Etoposide (administration & dosage, adverse effects, therapeutic use)
  • Female
  • Hematologic Neoplasms (drug therapy, pathology)
  • Humans
  • Male
  • Middle Aged
  • Remission Induction
  • Salvage Therapy